
Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC): An Evolving Diagnostic and Therapeutic Paradigm
Overview
Joshua F. Zeidner, MD, will discuss the evolving diagnostic algorithm for AML-MRC, prognosis, treatment outcomes, and unmet needs.
Target Audience
These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, registered nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, allied health personnel, and others who are interested in care for patients and survivors in North Carolina.
Learning Objectives
- Recall the different World Health Organization Subtypes of AML
- Describe the diagnostic criteria of AML-MRC
- List prognosis, treatment options, and emerging therapies for AML-MRC
Taking the Course
To continue, click the button Take Course.
If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at unclcn@unc.edu or (919) 445–1000.
Program
![]() | Cancer Treatment in North Carolina: Research to Practice (formerly Medical and Surgical Oncology) webinars cover the spectrum of anti-cancer therapy, with a focus on recent research developments, both locally and at large, and what’s ready for regular practice. Perspectives from medical oncology, radiation oncology, and surgery will be included. These webinars provide FREE continuing education credit. |
Faculty
![]() | Joshua F. Zeidner, MD Assistant Professor |
Accreditation
This Non-Credit Course does not have accreditation. It only offers general participation certificates. |
Available Credit
- 1.00 Participation
Register/Take course
You must have an account and be logged in to register for and to access the course.
Requirements for Receiving Free General Participation Certificates
|